Evidence map›Paper›PMID 35338144›Full record

ArticleNature communications2022

MERS-CoV ORF4b employs an unusual binding mechanism to target IMPα and block innate immunity.

Thilini S Munasinghe, Megan R Edwards, Sofiya Tsimbalyuk, Olivia A Vogel, Kate M Smith, Murray Stewart, Justin K Foster, Loretta A Bosence, David Aragão, Justin A Roby and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  10. Article
  11. Human coronaviruses: activation and antagonism of innate immune responses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  12. Anti-interferon armamentarium of human coronaviruses.Cellular and molecular life sciences : CMLS · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Recurrent viral capture of cellular phosphodiesterases that antagonize OAS-RNase L.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Thilini S Munasinghe *School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia.ORCID 0000-0002-9621-2555
Megan R Edwards *Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA.
Sofiya TsimbalyukSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia.
Olivia A VogelCenter for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA.
Kate M SmithPaul Scherrer Institut, Swiss Light Source, 5232, Villigen PSI, Switzerland.ORCID 0000-0002-1183-8832
Murray StewartMRC Laboratory of Molecular Biology, Francis Crick Ave., Cambridge Biomedical Campus, Cambridge, CB2 0QH, UK.
Justin K FosterSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia.
Loretta A BosenceSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia.
David AragãoDiamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK.ORCID 0000-0002-6551-4657
Justin A RobySchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia. jroby@csu.edu.au.ORCID 0000-0003-2434-4273
Christopher F BaslerCenter for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA. chris.basler@mssm.edu.ORCID 0000-0003-4195-425X
Jade K ForwoodSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia. jforwood@csu.edu.au.ORCID 0000-0003-3267-9997
Charles Sturt University · AUGeorgia State University · USDiamond Light Source · GBMRC Laboratory of Molecular Biology · GBPaul Scherrer Institute · CH

Funding

Virology BSL4 CoreP01AI120943 · NIAID · WASHINGTON UNIVERSITY · PI Gaya K. Amarasinghe · 2016 to 2026
$30.2M
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunityR21AI164080 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BASLER, CHRISTOPHER F · 2021 to 2022
$410k
Structural Basis for Henipavirus Matrix Protein Nucleo-Cytoplasmic TraffickingR21AI144880 · NIAID · GEORGIA STATE UNIVERSITY · PI BASLER, CHRISTOPHER F · 2019 to 2020
$383k
Department of Health | National Health and Medical Research Council (NHMRC) APP2003636NIAID NIH HHS P01 AI120943NIAID NIH HHS R21 AI144880NIAID NIH HHS R21 AI164080
6 · The paper itself

Abstract

The MERS coronavirus (MERS-CoV) is a highly pathogenic, emerging virus that produces accessory proteins to antagonize the host innate immune response. The MERS-CoV ORF4b protein has been shown to bind preferentially to the nuclear import adapter IMPα3 in infected cells, thereby inhibiting NF-κB-dependent innate immune responses. Here, we report high-resolution structures of ORF4b bound to two distinct IMPα family members. Each exhibit highly similar binding mechanisms that, in both cases, lack a prototypical Lys bound at their P2 site. Mutations within the NLS region dramatically alter the mechanism of binding, which reverts to the canonical P2 Lys binding mechanism. Mutational studies confirm that the novel binding mechanism is important for its nuclear import, IMPα interaction, and inhibition of innate immune signaling pathways. In parallel, we determined structures of the nuclear binding domain of NF-κB component p50 bound to both IMPα2 and α3, demonstrating that p50 overlaps with the ORF4b binding sites, suggesting a basis for inhibition. Our results provide a detailed structural basis that explains how a virus can target the IMPα nuclear import adapter to impair immunity, and illustrate how small mutations in ORF4b, like those found in closely related coronaviruses such as HKU5, change the IMPα binding mechanism.

Indexed as

Coronavirus InfectionsMiddle East Respiratory Syndrome CoronavirusHost-Pathogen InteractionsHumansImmunity, InnateNF-kappa BNF-kappa B

Identifiers

PMID35338144
PMCPMC8956657
OpenAlexW4220807705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.